SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001213900-19-011491
Filing Date
2019-06-26
Accepted
2019-06-26 12:16:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g0619kretzmer_enlivex.htm SC 13G 42084
  Complete submission text file 0001213900-19-011491.txt   43865
Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042
Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042 972 (0) 3 7326616
Enlivex Therapeutics Ltd. (Subject) CIK: 0001596812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88278 | Film No.: 19920753
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1185 AVENUE OF THE AMERICAS SUITE 300, THIRD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS SUITE 300, THIRD FLOOR NEW YORK NY 10036 917-912-9211
Kretzmer & Associates PLLC (Filed by) CIK: 0001780477 (see all company filings)

IRS No.: 260624814 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G